US · SOPH
SOPHiA GENETICS S.A.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Rolle 1025
- Website
- sophiagenetics.com
Price · as of 2024-12-31
$5.32
Market cap 305.31M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $25.26 | +374.81% |
| Intrinsic Value(DCF) | $1.31 | -75.38% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $9.94 | $28.72 | $5.49 | $0.00 | $0.00 |
| 2022 | $3.46 | $24.58 | $1.23 | $0.00 | $0.00 |
| 2023 | $4.73 | $28.66 | $1.63 | $0.00 | $0.00 |
| 2024 | $3.24 | $25.26 | $0.01 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates SOPHiA GENETICS S.A.'s (SOPH) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $25.26
- Current price
- $5.32
- AI upside
- +374.81%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.31
-75.38% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| SOPH | SOPHiA GENETICS S.A. | $5.32 | 305.31M | +375% | -75% | — | — | -3.48 | 2.21 | 3.27 | -3.21 | — | 3.16 | 67.42% | -102.14% | -95.89% | -49.42% | -143.02% | -33.90% | 0.31 | -34.80 | 3.71 | 3.32 | 0.99 | -2213.00% | 449.00% | -1177.00% | -23.93% | -1.60 | -109.57% | 0.00% | 0.00% | 0.00% | -2.45 | -3.19 | 2.50 | -2.23 |
| ACIU | AC Immune S.A. | $2.93 | 294.76M | +1,817% | -50% | — | — | -3.77 | 1.71 | 7.03 | -0.66 | — | 3.10 | -129.12% | -191.80% | -186.44% | -37.31% | -787.64% | -24.61% | 0.05 | -393.82 | 1.71 | 1.65 | 0.63 | -2031.00% | 8451.00% | -20663.00% | 34.00% | 0.65 | 981.44% | 0.00% | 0.00% | 0.00% | -0.61 | 0.49 | 1.17 | -1.52 |
| AGL | Agilon Health, Inc. | $0.59 | 244.31M | +3,319% | +1,042% | — | — | -0.65 | 2.01 | 0.04 | 0.03 | -1.17 | 4.18 | -3.18% | -7.10% | -6.83% | -130.95% | 2821.09% | -26.04% | 0.15 | -63.41 | 1.02 | 0.89 | 0.42 | 5556.00% | -211.00% | 6755.00% | -46.67% | -0.10 | 797.30% | 0.00% | 0.00% | 2.97% | 0.03 | 0.09 | 0.00 | 1.55 |
| ANRO | Alto Neuroscience, Inc. | $19.69 | 611.7M | — | — | — | — | -1.42 | 0.58 | — | 0.93 | -1.67 | 0.58 | 0.00% | — | — | -153.99% | 95.25% | -46.51% | 0.11 | 49.90 | 16.92 | 16.81 | 2.20 | 8519.00% | — | 4594.00% | -56.68% | -4.74 | 68.72% | 0.00% | 0.00% | 90.14% | 0.93 | 1.29 | — | 0.72 |
| CLLS | Cellectis S.A. | $3.88 | 389.18M | +21,055% | +605% | — | — | -3.10 | 0.87 | 2.74 | 5.83 | — | 0.87 | 77.88% | -143.48% | -88.57% | -34.02% | 165.71% | -10.22% | 0.70 | -7.99 | 1.73 | 1.70 | 5.47 | -7684.00% | 539748.00% | -17562.00% | 17.18% | 0.13 | -54.33% | 0.00% | 0.00% | 0.12% | 0.93 | -2.83 | -1.33 | -0.96 |
| DH | Definitive Healthcare Cor… | $1.28 | 132.23M | +1,820% | +27% | — | — | -0.61 | 0.32 | 0.50 | 0.32 | — | -1.85 | 75.88% | -8.52% | -57.52% | -48.41% | -6.39% | -21.84% | 0.02 | -1.82 | 1.64 | 1.49 | 0.96 | -6328.00% | -424.00% | -1918.00% | 30.48% | 0.34 | 12.09% | 0.00% | 0.00% | 290.32% | 2.50 | -1.39 | -0.21 | 0.60 |
| LRMR | Larimar Therapeutics, Inc… | $5.31 | 454.48M | — | — | — | — | -2.30 | 1.08 | — | -0.08 | -4.03 | 1.08 | 0.00% | — | — | -63.58% | 3005.12% | -54.43% | 0.03 | — | 8.02 | 7.58 | 0.31 | 5714.00% | — | 11198.00% | -38.40% | -2.91 | 2356.59% | 0.00% | 0.00% | 3.72% | -0.08 | -0.10 | — | 1.56 |
| NAKA | Nakamoto Inc. | $0.25 | 92.19M | +34,449% | +169% | — | +4,954% | -2.46 | 3.46 | 3.27 | -2.47 | -1.66 | 4.08 | 96.96% | -123.05% | -133.01% | -294.13% | -619.29% | -151.45% | 0.31 | -8.51 | 4.13 | 3.81 | 0.50 | 14815.00% | -2783.00% | 64918.00% | -39.07% | -5.07 | -643.12% | 0.00% | 0.00% | 18.24% | -2.21 | -2.13 | 2.72 | 0.21 |
| NRC | National Research Corpora… | $13.41 | 303.84M | +162% | -57% | — | -83% | 26.72 | 22.16 | 2.26 | 12.73 | — | -5.94 | 56.33% | 16.44% | 8.44% | 51.24% | 16.29% | 8.68% | 5.65 | 4.74 | 0.55 | 0.42 | 2.48 | -5000.00% | -396.00% | -1790.00% | 5.08% | 0.72 | 17.46% | 3.54% | 94.60% | 10.05% | 17.04 | 24.45 | 2.80 | 2.78 |
| OPRX | OptimizeRx Corporation | $7.58 | 141.3M | +1,777% | -62% | — | — | -4.17 | 0.72 | 0.91 | -11.65 | -61.30 | 136.67 | 64.45% | -14.88% | -21.83% | -16.51% | -9.57% | -11.34% | 0.28 | -2.23 | 2.89 | 2.77 | -2.23 | 680.00% | 2881.00% | -15890.00% | 5.70% | 0.26 | 3.34% | 0.00% | 0.00% | 4.86% | -7.56 | 21.69 | 1.12 | 0.76 |
| SLP | Simulations Plus, Inc. | $12.23 | 246.39M | +509% | -44% | — | — | -5.32 | 2.76 | 4.35 | 21.26 | — | 6.64 | 58.38% | -89.33% | -81.74% | -42.13% | -51.50% | -38.12% | 0.00 | — | 7.67 | 6.98 | -2.06 | -75714.00% | 1309.00% | 3653.00% | 5.06% | 2.70 | 13.59% | 0.00% | 0.00% | 6.08% | -4.42 | 17.95 | 3.95 | 27.83 |
About SOPHiA GENETICS S.A.
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
- CEO
- Jurgi Camblong
- Employees
- 423
- Beta
- 1.11
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.31 ÷ $5.32) − 1 = -75.38% (DCF, example).